Wird geladen...
Berzosertib (VE-822) inhibits gastric cancer cell proliferation via base excision repair system
BACKGROUND: Current investigations suggest that the Base Excision Repair (BER) system may change DNA repair capacity and affect clinical gastric cancer progression such as overall survival. However, the prognostic value of BER system members in gastric cancer remains unclear. METHODS: We explored th...
Gespeichert in:
| Veröffentlicht in: | Cancer Manag Res |
|---|---|
| Hauptverfasser: | , , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Dove
2019
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6750847/ https://ncbi.nlm.nih.gov/pubmed/31571995 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CMAR.S217375 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|